Take charge of your finances with these top budget monitoring apps that make tracking spending simple, smart, and stress-free.
Updated
January 8, 2026 6:36 PM
.webp)
A phone next to a laptop, displaying a stock market app. PHOTO: UNSPLASH
Managing personal finances can feel overwhelming, especially with the countless expenses we juggle daily. Thankfully, budget monitoring apps are hereto save the day. These handy tools help you track your spending, set financial goals, and build better money habits—all from the convenience of your smartphone.
Whether you're saving for a vacation, paying off debt, or just trying to avoid those end-of-the-month surprises, budget tracker apps can provide clarity and control over your finances. Here are 5 budget monitoring apps that will keep your spending on track.
If simplicity is what you’re after, Monefy is the solution. Known for its highly intuitive interface, Monefy lets users track their spending with just a few taps. Unlike many budget apps that overwhelm you with features, Monefy focuses on the essentials, making it great for beginners or anyone looking for a straightforward way to manage their money.
Monefy is perfect for users who want a no-frills app to track spending or beginners just dipping their toes into budgeting.
Budgeting doesn’t have to feel like a chore, and Fortune City proves just that. This app gamifies your financial habits by turning expense tracking into a city-building game. Every category of spending contributes to your virtual city’s development, making it an enjoyable way to visualize where your money is going.
Fortune City is ideal for those who find traditional budgeting boring or intimidating and want a fun way to stay consistent.
Jupiter combines the best of both worlds: digital banking and budgeting. This app integrates directly with your bank account, automatically categorizing transactions and providing insights into your spending patterns. It’s not just a budget tracker—it’s a full-fledged financial assistant.
Jupiter is best for users who want a hands-off budgeting experience and prefer an all-in-one app for banking and money management.
Inspired by the envelope budgeting method, GoodBudget offers a digital twist on this classic approach. Instead of physical envelopes, you allocate your money into virtual "envelopes" for different spending categories. This app encourages disciplined spending and is particularly effective for budgeters who like to plan ahead.
GoodBudget is ideal for planners who like a structured approach to budgeting and don’t mind manual tracking.
Wally is a feature-packed app designed for users who want deep insights into their spending habits. Its sleek design, multi-currency support, and detailed financial reports make it a standout option, especially for frequent travelers or professionals juggling multiple accounts.
Wally is perfect for users who want advanced budgeting tools and detailed insights, especially those with international financial needs.
Budget monitoring apps are powerful tools that simplify the often-daunting task of managing your finances. Whether you’re drawn to the playful gamification of Fortune City, the structured approach of GoodBudget, or the all-in-one convenience of Jupiter, there’s an app tailored to your preferences and goals.
These apps don’t just track your spending—they help you build better habits, gain financial clarity, and take control of your money. With the right app in your pocket, managing your budget becomes less of a chore and more of are warding journey toward financial freedom. So why wait? Choose an app, start tracking, and watch your financial confidence grow!
Keep Reading
How a Korean biotech startup is using AI to move drug discovery from trial-and-error to precision design

A close up of a protein structure model. PHOTO: UNSPLASH
For decades, drug discovery has relied on trial and error, with scientists testing thousands of molecules to find one that works. Galux, a South Korean biotech startup, is changing that by using AI to design proteins from scratch. This method, called “de novo” design, makes it possible to build precise new therapies instead of searching through existing ones.
The company recently announced a US$29 million Series B funding round, bringing its total capital to US$47 million.This significant investment attracted a substantial roster of institutional backers, including the Korea Development Bank (KDB), Yuanta Investment, SL Investment and NCORE Ventures. These firms joined existing investors such as InterVest, DAYLI Partners and PATHWAY Investment, as well as new participants including SneakPeek Investments, Korea Investment & Securities and Mirae Asset Securities.
At the core of the company’s work is a platform called GaluxDesign. Unlike many AI tools that only predict how existing proteins fold, this system uses deep learning and physics to create entirely new therapeutic antibodies. This “from scratch” approach lets the team go after so-called “undruggable” proteins. These are targets that traditional small-molecule drugs can’t reach because they lack clear binding pockets. By designing proteins to fit these complex shapes, Galux aims to unlock treatments that have stayed out of reach for decades. And that’s exactly why investors are paying attention.
The pharmaceutical industry is actively looking for faster and more efficient ways to develop new drugs, and Galux is built for exactly that. The company connects its AI platform directly to its own wet lab, where designs can be tested in real time. Each result feeds straight back into the system, sharpening the next round of models. This continuous loop speeds up discovery and improves precision at every step. It’s also why partners like Celltrion, LG Chem and Boehringer Ingelheim are already working with Galux.
Galux is no longer just trying to make drugs that stick to a target. The company now wants its AI to design medicines that actually work in the body and can be made at scale. In simple terms, a drug has to do more than bind to a disease—it must be stable, safe and strong enough to change how the illness behaves. Galux is moving into tougher targets such as ion channels and GPCRs. These play key roles in heart function and sensory signals. Ultimately, the goal is to show that AI-driven design can turn complex biology into real treatments. And instead of hunting blindly for a solution, the team is building exactly what they need.